Savara Pharmaceuticals
SVRA
#6617
Rank
A$0.87 B
Marketcap
$5.10
Share price
-1.23%
Change (1 day)
-25.76%
Change (1 year)

Savara Pharmaceuticals (SVRA) - Cash on Hand

Cash on Hand as of September 2024 : A$0.34 Billion

According to Savara Pharmaceuticals's latest financial reports the company has A$0.34 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Savara Pharmaceuticals - Cash on Hand chart (from 2002 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$0.23 B28.8%
2022-12-31A$0.18 B-16.79%
2021-12-31A$0.22 B107.99%
2020-12-31A$0.10 B-38.54%
2019-12-31A$0.17 B10.54%
2018-12-31A$0.15 B30.23%
2017-12-31A$0.12 B551.16%
2016-12-31A$18.55 M-67.02%
2015-12-31A$56.25 M-19.64%
2014-12-31A$70 M40.66%
2013-12-31A$49.76 M41.65%
2012-12-31A$35.13 M-28.95%
2011-12-31A$49.45 M79.53%
2010-12-31A$27.54 M185.48%
2009-12-31A$9.64 M-30.89%
2008-12-31A$13.96 M-63.52%
2007-12-31A$38.27 M-41.69%
2006-12-31A$65.64 M112.59%
2005-12-31A$30.87 M83.35%
2004-12-31A$16.84 M196.18%
2003-12-31A$5.68 M2982.41%
2002-12-31A$0.18 M-42.76%
2001-12-31A$0.32 M-87.86%
2000-12-31A$2.65 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$25.94 M-92.53%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.64 B 85.20%๐Ÿ‡บ๐Ÿ‡ธ USA